NORBERT W BISCHOFBERGER Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT W BISCHOFBERGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT W BISCHOFBERGER. NORBERT W BISCHOFBERGER is EVP, R&D and CSO in GILEAD SCIENCES INC ($GILD).
NORBERT W BISCHOFBERGER in GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NORBERT W BISCHOFBERGER: EVP, R&D and CSO
Holdings: 165,168 shares
Current Value: $12,078,736
Latest Transaction: Feb 19 2015
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NORBERT W BISCHOFBERGER in GILEAD SCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 70,000 | 1,147,650 | 20,000 | |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 103.26 | 40,886 | 4,222,048 | 165,168 | 206.1 K to 165.2 K (-19.84 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 102.66 | 29,114 | 2,988,692 | 206,054 | 235.2 K to 206.1 K (-12.38 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 70,000 | 1,147,650 | 235,168 | 165.2 K to 235.2 K (+42.38 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 103.84 | 83,490 | 8,669,602 | 165,168 | 248.7 K to 165.2 K (-33.58 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 106,668 | 0 | 248,658 | 142 K to 248.7 K (+75.12 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 22,440 | 0 | 141,990 | 119.6 K to 142 K (+18.77 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 85.61 | 248 | 21,232 | 119,550 | 119.3 K to 119.6 K (+0.21 %) |
| Feb 03 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 104.83 | 62,020 | 6,501,557 | 62,020 | |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 70,000 | 1,147,650 | 90,000 | |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.62 | 11,679 | 1,163,419 | 119,302 | 131 K to 119.3 K (-8.92 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 98.77 | 26,179 | 2,585,781 | 130,981 | 157.2 K to 131 K (-16.66 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 97.81 | 32,142 | 3,143,883 | 157,160 | 189.3 K to 157.2 K (-16.98 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 70,000 | 1,147,650 | 189,302 | 119.3 K to 189.3 K (+58.67 %) |
| Aug 15 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 4,000 | 0 | 2,154,681 | 2.2 M to 2.2 M (-0.19 %) |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 160,000 | |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 80.90 | 90,000 | 7,280,784 | 119,302 | 209.3 K to 119.3 K (-43.00 %) |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| May 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 250,000 | |
| May 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 81.14 | 41,336 | 3,354,123 | 119,302 | 160.6 K to 119.3 K (-25.73 %) |
| May 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 80.24 | 48,664 | 3,904,629 | 160,638 | 209.3 K to 160.6 K (-23.25 %) |
| May 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 340,000 | |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 68.01 | 7,703 | 523,853 | 119,302 | 127 K to 119.3 K (-6.07 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 67.23 | 50,307 | 3,382,119 | 127,005 | 177.3 K to 127 K (-28.37 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 66.47 | 31,990 | 2,126,510 | 177,312 | 209.3 K to 177.3 K (-15.28 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| Mar 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 430,000 | |
| Mar 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 76.83 | 2,700 | 207,454 | 119,302 | 122 K to 119.3 K (-2.21 %) |
| Mar 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 76.25 | 48,488 | 3,697,433 | 122,002 | 170.5 K to 122 K (-28.44 %) |
| Mar 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 75.36 | 38,812 | 2,924,818 | 170,490 | 209.3 K to 170.5 K (-18.54 %) |
| Mar 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 79.92 | 54,790 | 4,378,817 | 119,302 | 174.1 K to 119.3 K (-31.47 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 105,000 | 0 | 174,092 | 69.1 K to 174.1 K (+151.97 %) |
| Mar 10 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 21.94 | 968 | 21,243 | 69,092 | 68.1 K to 69.1 K (+1.42 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 0 | |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 82.75 | 3,900 | 322,723 | 68,124 | 72 K to 68.1 K (-5.41 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 81.99 | 13,586 | 1,113,885 | 72,024 | 85.6 K to 72 K (-15.87 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 81.17 | 72,514 | 5,885,613 | 85,610 | 158.1 K to 85.6 K (-45.86 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 158,124 | 68.1 K to 158.1 K (+132.11 %) |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 80.65 | 57,180 | 4,611,567 | 57,180 | |
| Jan 27 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 14,792 | 0 | 68,124 | 53.3 K to 68.1 K (+27.74 %) |
| Jan 27 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 26,666 | 0 | 53,332 | 26.7 K to 53.3 K (+100.00 %) |
| Jan 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 90,000 | |
| Jan 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 75.02 | 24,851 | 1,864,344 | 0 | 24.9 K to 0 (-100.00 %) |
| Jan 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 74.41 | 27,078 | 2,014,934 | 24,851 | 51.9 K to 24.9 K (-52.14 %) |
| Jan 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 73.60 | 38,071 | 2,801,870 | 51,929 | 90 K to 51.9 K (-42.30 %) |
| Jan 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 90,000 | 0 to 90 K |
| Dec 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 180,000 | |
| Dec 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 71.75 | 90,000 | 6,457,941 | 0 | 90 K to 0 (-100.00 %) |
| Dec 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 90,000 | 0 to 90 K |
| Nov 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 270,000 | |
| Nov 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 4,000 | 0 | 2,158,681 | 2.2 M to 2.2 M (-0.18 %) |
| Nov 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 68.86 | 90,000 | 6,197,292 | 0 | 90 K to 0 (-100.00 %) |
| Nov 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 90,000 | 0 to 90 K |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 265,333 | 0 | 2,162,681 | 1.9 M to 2.2 M (+13.98 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 265,500 | 0 | 1,897,348 | 1.6 M to 1.9 M (+16.27 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 265,500 | 0 | 1,631,848 | 1.4 M to 1.6 M (+19.43 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 265,500 | 0 | 1,366,348 | 1.1 M to 1.4 M (+24.12 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 1,097,810 | 0 | 1,100,848 | 3 K to 1.1 M (+36,135.94 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 265,333 | 0 | 0 | 265.3 K to 0 (-100.00 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 265,500 | 0 | 265,333 | 530.8 K to 265.3 K (-50.02 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 265,500 | 0 | 530,833 | 796.3 K to 530.8 K (-33.34 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 265,500 | 0 | 796,333 | 1.1 M to 796.3 K (-25.00 %) |
| Oct 22 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 1,097,810 | 0 | 1,061,833 | 2.2 M to 1.1 M (-50.83 %) |
| Oct 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 360,000 | |
| Oct 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 63.29 | 14,147 | 895,430 | 2,159,643 | 2.2 M to 2.2 M (-0.65 %) |
| Oct 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 62.39 | 75,853 | 4,732,757 | 2,173,790 | 2.2 M to 2.2 M (-3.37 %) |
| Oct 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 2,249,643 | 2.2 M to 2.2 M (+4.17 %) |
| Sep 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 450,000 | |
| Sep 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 63.93 | 6,427 | 410,876 | 2,159,643 | 2.2 M to 2.2 M (-0.30 %) |
| Sep 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 63.05 | 83,573 | 5,269,085 | 2,166,070 | 2.2 M to 2.2 M (-3.71 %) |
| Sep 18 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 2,249,643 | 2.2 M to 2.2 M (+4.17 %) |
| Aug 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 540,000 | |
| Aug 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 59.29 | 9,193 | 545,034 | 2,159,643 | 2.2 M to 2.2 M (-0.42 %) |
| Aug 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 58.71 | 80,807 | 4,743,848 | 2,168,836 | 2.2 M to 2.2 M (-3.59 %) |
| Aug 16 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 2,249,643 | 2.2 M to 2.2 M (+4.17 %) |
| Jul 17 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 630,000 | |
| Jul 17 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 57.33 | 90,000 | 5,160,132 | 2,159,643 | 2.2 M to 2.2 M (-4.00 %) |
| Jul 17 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 2,249,643 | 2.2 M to 2.2 M (+4.17 %) |
| Mar 08 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 45.40 | 12,523 | 568,544 | 2,159,643 | 2.2 M to 2.2 M (-0.58 %) |
| Mar 08 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 24,000 | 0 | 2,172,166 | 2.1 M to 2.2 M (+1.12 %) |
| Feb 05 2013 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 40.56 | 134,660 | 5,461,810 | 134,660 | |
| Dec 20 2012 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 2,620 | 0 | 1,073,599 | 1.1 M to 1.1 M (-0.24 %) |
| Jul 03 2012 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 29.02 | 733 | 21,271 | 1,076,219 | 1.1 M to 1.1 M (+0.07 %) |
| Mar 14 2012 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 46.16 | 8,767 | 404,685 | 1,075,486 | 1.1 M to 1.1 M (-0.81 %) |
| Mar 14 2012 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 19,800 | 0 | 1,084,253 | 1.1 M to 1.1 M (+1.86 %) |
| Jan 30 2012 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 48.59 | 116,250 | 5,648,588 | 116,250 | |
| Mar 17 2011 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 39.79 | 7,876 | 313,386 | 1,061,922 | 1.1 M to 1.1 M (-0.74 %) |
| Mar 17 2011 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 16,875 | 0 | 1,069,798 | 1.1 M to 1.1 M (+1.60 %) |
| Jan 24 2011 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 38.17 | 119,000 | 4,542,230 | 119,000 | |
| Nov 24 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 5,275 | 0 | 1,519 | 6.8 K to 1.5 K (-77.64 %) |
| Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 47.01 | 12,136 | 570,513 | 1,052,346 | 1.1 M to 1.1 M (-1.14 %) |
| Mar 10 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 26,000 | 0 | 1,064,482 | 1 M to 1.1 M (+2.50 %) |
| Feb 26 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 53,754 | 860,602 | 0 | |
| Feb 26 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 6,246 | 99,998 | 0 | |
| Feb 26 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 47.49 | 53,754 | 2,552,589 | 1,038,482 | 1.1 M to 1 M (-4.92 %) |
| Feb 26 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 53,754 | 860,602 | 1,092,236 | 1 M to 1.1 M (+5.18 %) |
| Feb 26 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 6,246 | 99,998 | 1,038,482 | 1 M to 1 M (+0.61 %) |
| Feb 01 2010 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 47.51 | 72,000 | 3,420,720 | 72,000 | |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 30,000 | 480,300 | 53,754 | |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 5,600 | 0 | 6,794 | 12.4 K to 6.8 K (-45.18 %) |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 47.16 | 2,000 | 94,319 | 12,394 | 14.4 K to 12.4 K (-13.89 %) |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 47.16 | 17,920 | 845,098 | 1,032,236 | 1.1 M to 1 M (-1.71 %) |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 46.91 | 30,000 | 1,407,348 | 1,050,156 | 1.1 M to 1.1 M (-2.78 %) |
| Nov 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 30,000 | 480,300 | 1,080,156 | 1.1 M to 1.1 M (+2.86 %) |
| Jul 28 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 140,000 | 2,241,400 | 83,754 | |
| Jul 28 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 48.00 | 40,448 | 1,941,492 | 1,050,156 | 1.1 M to 1.1 M (-3.71 %) |
| Jul 28 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 48.00 | 140,000 | 6,719,832 | 1,090,604 | 1.2 M to 1.1 M (-11.38 %) |
| Jul 28 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 140,000 | 2,241,400 | 1,230,604 | 1.1 M to 1.2 M (+12.84 %) |
| May 26 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 100,000 | 1,601,000 | 223,754 | |
| May 26 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 42.64 | 30,000 | 1,279,341 | 14,394 | 44.4 K to 14.4 K (-67.58 %) |
| May 26 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 42.61 | 100,000 | 4,260,880 | 1,090,125 | 1.2 M to 1.1 M (-8.40 %) |
| May 26 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 100,000 | 1,601,000 | 1,190,125 | 1.1 M to 1.2 M (+9.17 %) |
| Mar 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 44.04 | 5,948 | 261,950 | 1,090,125 | 1.1 M to 1.1 M (-0.54 %) |
| Mar 16 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 13,000 | 0 | 1,096,073 | 1.1 M to 1.1 M (+1.20 %) |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 15.27 | 6,548 | 99,955 | 0 | |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.01 | 20,000 | 320,200 | 323,754 | |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 15.27 | 153,452 | 2,342,445 | 0 | |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 15.27 | 6,548 | 99,955 | 1,083,073 | 1.1 M to 1.1 M (+0.61 %) |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.70 | 7,594 | 400,218 | 1,076,525 | 1.1 M to 1.1 M (-0.70 %) |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.43 | 165,858 | 8,696,416 | 1,084,119 | 1.2 M to 1.1 M (-13.27 %) |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.01 | 20,000 | 320,200 | 1,249,977 | 1.2 M to 1.2 M (+1.63 %) |
| Feb 09 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 15.27 | 153,452 | 2,342,445 | 1,229,977 | 1.1 M to 1.2 M (+14.25 %) |
| Jan 23 2009 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 47.20 | 79,200 | 3,738,240 | 79,200 | |
| Nov 21 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 5,000 | 0 | 44,394 | 49.4 K to 44.4 K (-10.12 %) |
| Nov 12 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 15.27 | 150,000 | 2,289,750 | 153,452 | |
| Nov 12 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 44.75 | 40,000 | 1,790,000 | 49,394 | 89.4 K to 49.4 K (-44.75 %) |
| Nov 12 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 45.10 | 150,000 | 6,765,330 | 1,076,525 | 1.2 M to 1.1 M (-12.23 %) |
| Nov 12 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 15.27 | 150,000 | 2,289,750 | 1,226,525 | 1.1 M to 1.2 M (+13.93 %) |
| Jul 25 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 15.27 | 150,000 | 2,289,750 | 303,452 | |
| Jul 25 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.15 | 30,000 | 1,564,356 | 89,394 | 119.4 K to 89.4 K (-25.13 %) |
| Jul 25 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 52.07 | 150,000 | 7,810,530 | 1,076,525 | 1.2 M to 1.1 M (-12.23 %) |
| Jul 25 2008 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 15.27 | 150,000 | 2,289,750 | 1,226,525 | 1.1 M to 1.2 M (+13.93 %) |
Page: 1